Cinctive Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-19,567	Closed	-$456K	–	436
2024 Q4	$456K	Sell	19,567 -41,689	-68%	-$971K	0.02%	304
2024 Q3	$1.8M	Buy	+61,256	New	+$1.8M	0.1%	228